Idexx Laboratories | IDXX

Stock Price
652.83
Daily Change
9.84 1.53%
Monthly
0.11%
Yearly
35.91%
Q3 Forecast
637.65


Financials
Assets USD 3.33B
Cash and Equivalent USD 164.59M
Cost of Sales USD 414.73M
Current Assets USD 1.36B
Current Liabilities USD 1.22B
Debt USD 1.24B
EBIT USD 373.05M
EBITDA USD 409.45M
Employees 11K
EPS Earnings Per Share USD 3.63
Equity Capital and Reserves USD -4.41B
Gross Profit on Sales USD 694.73M
Interest Expense on Debt USD 11.32M
Interest Income USD 627K
Loan Capital USD 449.81M
Market Capitalization USD 54.28B
Net Income USD 293.99M
Operating Expenses USD 736.41M
Operating Profit USD 373.05M
Ordinary Share Capital USD 80.42M
PE Price to Earnings USD 44.65
Pre-Tax Profit USD 362.35M
Sales Revenues USD 1.11B
Selling and Administration Expenses USD 259.79M
Stock USD 392.58M
Trade Creditors USD 116.59M
Trade Debtors USD 560.56M
Peers Price Chg Day Year Date
Fujifilm 3,599.00 -71.00 -1.93% -5.54% Sep/09
Abbott 132.25 -0.69 -0.52% 13.61% Sep/08
Align Technology 136.88 -2.24 -1.61% -38.15% Sep/08
Dexcom 78.01 -2.50 -3.11% 11.99% Sep/08
Edwards Lifesciences 80.21 -0.73 -0.90% 22.19% Sep/08
Globus Medical 59.55 -1.05 -1.73% -14.95% Sep/08
Hologic 66.54 -0.22 -0.33% -19.53% Sep/08
Henry Schein 67.74 -1.69 -2.43% -1.67% Sep/08
Integra LifeSciences 15.68 -0.31 -1.94% -10.76% Sep/08
Idexx Laboratories 652.83 9.84 1.53% 35.91% Sep/08
Intuitive Surgical 470.00 3.14 0.67% -1.83% Sep/08
Masimo 148.79 1.60 1.09% 33.61% Sep/08
Neogen 5.66 -0.09 -1.57% -63.13% Sep/08
Insulet 349.56 1.13 0.32% 59.52% Sep/08
ResMed 279.46 2.41 0.87% 11.89% Sep/08
Roche Holding 270.10 -4.10 -1.50% 1.09% Sep/08
Steris 248.32 3.02 1.23% 1.16% Sep/08
Teleflex 130.18 -0.52 -0.40% -46.90% Sep/08
Thermo Fisher Scientific 487.65 -4.95 -1.00% -21.35% Sep/08
Tandem Diabetes Care 12.50 -0.08 -0.64% -70.41% Sep/08
Dentsply International 14.21 -0.41 -2.80% -43.97% Sep/08
Zoetis 151.75 -1.57 -1.02% -20.90% Sep/08

Indexes Price Day Year Date
USND 21799 98.31 0.45% 29.10% Sep/08
US500 6503 13.66 0.21% 18.33% Sep/09
US100 23811 109.86 0.46% 26.46% Sep/09

Idexx Laboratories traded at $652.83 this Monday September 8th, increasing $9.84 or 1.53 percent since the previous trading session. Looking back, over the last four weeks, Idexx Laboratories gained 0.11 percent. Over the last 12 months, its price rose by 35.91 percent. Looking ahead, we forecast Idexx Laboratories to be priced at 637.65 by the end of this quarter and at 621.91 in one year, according to Trading Economics global macro models projections and analysts expectations.

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. It also sells a line of portable electrolytes and blood gas analyzers used in the human diagnostics market. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.